Day One Biopharmaceuticals (DAWN) Other Gross PP&E Adjustments (2022 - 2025)
Historic Other Gross PP&E Adjustments for Day One Biopharmaceuticals (DAWN) over the last 4 years, with Q3 2025 value amounting to -$8.2 million.
- Day One Biopharmaceuticals' Other Gross PP&E Adjustments fell 5079.57% to -$8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.2 million, marking a year-over-year decrease of 5079.57%. This contributed to the annual value of -$6.2 million for FY2024, which is 2053.83% down from last year.
- As of Q3 2025, Day One Biopharmaceuticals' Other Gross PP&E Adjustments stood at -$8.2 million, which was down 5079.57% from -$6.5 million recorded in Q2 2025.
- Over the past 5 years, Day One Biopharmaceuticals' Other Gross PP&E Adjustments peaked at -$1.2 million during Q1 2022, and registered a low of -$8.2 million during Q3 2025.
- In the last 4 years, Day One Biopharmaceuticals' Other Gross PP&E Adjustments had a median value of -$3.8 million in 2024 and averaged -$4.3 million.
- Over the last 5 years, Day One Biopharmaceuticals' Other Gross PP&E Adjustments had its largest YoY gain of 1614.33% in 2023, and its largest YoY loss of 21545.69% in 2023.
- Quarter analysis of 4 years shows Day One Biopharmaceuticals' Other Gross PP&E Adjustments stood at -$2.8 million in 2022, then crashed by 82.72% to -$5.1 million in 2023, then fell by 20.54% to -$6.2 million in 2024, then plummeted by 33.4% to -$8.2 million in 2025.
- Its Other Gross PP&E Adjustments was -$8.2 million in Q3 2025, compared to -$6.5 million in Q2 2025 and -$7.5 million in Q1 2025.